Celularity (CELU) Total Debt (2018 - 2025)
Celularity's (CELU) quarterly Total Debt came in at $9.7 million in Q4 2025, down 77.9% year-over-year from $43.7 million in Q4 2024, and up 12.69% quarter-over-quarter from $8.6 million in Q3 2025.
Analysis
Celularity (CELU) Total Debt (2018 - 2025) Analysis & Trends
Celularity (CELU) has reported Total Debt for 6 consecutive years, with $9.7 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Total Debt fell 77.9% year-over-year to $9.7 million in Q4 2025; TTM through Dec 2025 was $9.7 million, a 77.9% decrease from a year earlier, with the FY2025 full-year figure at $9.7 million, down 77.9% from the prior year.
- Total Debt was $9.7 million for Q4 2025 at Celularity, up from $8.6 million in the prior quarter.
- Over five years, Total Debt peaked at $78.5 million in Q3 2022 and troughed at $120000.0 in Q1 2021.
- A 5-year average of $37.4 million and a median of $43.7 million in 2024 frame the typical range for Total Debt.
- Across the five-year window, Total Debt advanced 26.8% in 2024 and tumbled 77.9% in 2025, its largest moves.
- Over 5 years, Total Debt stood at $1.1 million in 2021, then soared by 6679.77% to $75.2 million in 2022, then plunged by 54.2% to $34.4 million in 2023, then climbed by 26.8% to $43.7 million in 2024, then plunged by 77.9% to $9.7 million in 2025.
- The last three Total Debt figures came in at $9.7 million (Q4 2025), $8.6 million (Q3 2025), and $45.1 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | 586.20 Mn |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | 156.40 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 50.15 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | 112.43 Mn |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 93.88 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | 847.62 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | - |
| 10 | Celularity | 36.35 Mn | 30.17 Mn | -3.27 Mn | 9.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 9.66 Mn |
| Sep 30, 2025 | 8.57 Mn |
| Jun 30, 2025 | 45.09 Mn |
| Mar 31, 2025 | 44.81 Mn |
| Dec 31, 2024 | 43.68 Mn |
| Dec 31, 2023 | 34.45 Mn |
| Sep 30, 2023 | 28.01 Mn |
| Jun 30, 2023 | 50.66 Mn |
| Mar 31, 2023 | 66.64 Mn |
| Dec 31, 2022 | 75.21 Mn |
| Sep 30, 2022 | 78.51 Mn |
| Jun 30, 2021 | 1.11 Mn |
| Mar 31, 2021 | 120,000.00 |
| Dec 31, 2018 | 150,000.00 |